Cite
HARVARD Citation
Lorenc, Z. et al. (2021). The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients. Aesthetic surgery journal. pp. 1423-1438. [Online].